A5061999122- HIV/AIDS Research and Interventions
- Hemoglobinopathies and Related Disorders
- HIV, Drug Use, Sexual Risk
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Bone health and osteoporosis research
- HIV/AIDS drug development and treatment
- Iron Metabolism and Disorders
- Eosinophilic Disorders and Syndromes
- Sex work and related issues
- Erythropoietin and Anemia Treatment
- Healthcare Systems and Practices
- Cardiac, Anesthesia and Surgical Outcomes
Adelphi Group (United Kingdom)
2022-2025
Limited data exist regarding treatment patterns and symptom burden of patients with anemia chronic kidney disease (CKD) in the Middle East, South Africa, Türkiye. This real-world study explored clinical characteristics, burden, CKD living Physician patient perceptions were captured via cross-sectional surveys; patients' characteristics recorded by retrospective review medical records. Data collected from 1788 217 physicians. A high proportion had never received for their (n = 701, 39.2%);...
Abstract Background Understanding the real-world experiences of people with HIV-1 (PWH) is essential to tailoring HIV treatment PWH needs. PAtIent Reported Experiences and perceiveD benefit dolutegravir/lamivudine (DTG/3TC) (PAIRED) examined in United States. Methods PAIRED comprised a cross-sectional survey in-depth qualitative interviews stable-switch ≥ 18 years, receiving DTG/3TC for 3 months. A mixed recruitment methodology (site-led community outreach) was employed, included validated...
Abstract Polycythemia vera (PV) is a myeloproliferative neoplasm associated with high symptom and psychological burden, resulting in decreased quality of life (QoL). Patients PV have an increased risk cardiovascular (CV) complications, making regular monitoring crucial. The Landmark 2.0 survey was conducted worldwide among patients their treating physicians to identify any potential gaps perceptions regarding management. Data were collected between April 2021 2022 from across 11 countries....
Review of medical records from 173 women with osteoporosis who received abaloparatide treatment revealed that 96.0% had at least one visit for management and 55.5% medication support group access. The most common reasons discontinuing were financial (31.2%) tolerability (22.8%). Most patients (64.8%) completed as prescribed.
Background: Uptake of pre-exposure prophylaxis (PrEP) in the United States (US) remains below target, despite reported high efficacy prevention HIV infection and being considered as a strategy for ending new transmissions. Here, we sought to investigate drivers PrEP use barriers increased uptake using real-world data. Methods: Data were drawn from Adelphi Disease Specific Programme™, cross-sectional survey users non-users at risk their physicians US between August 2021 March 2022. Physicians...
Topic: 35. Quality of life and palliative care Background: Polycythemia vera (PV) patients (pts) have a high risk thrombosis cardiovascular (CV) events are the main cause death. PV Pts also report reduced quality (QoL) due to symptom psychological burden. Aims: This study examined patterns in CV assessment PV-related burden, comparing results from physician (phys) pt perspectives. Methods: The LANDMARK 2.0 survey pts phys was conducted 11 countries between April 2021–May 2022. aged 18–89...
Abstract Background Although pre-exposure prophylaxis (PrEP) is recommended for people at risk of acquiring HIV, usage remains low. Our study used real-world data to characterise the factors driving decision-making in PrEP use, among current users (PU) and at-risk non-users (NU). Methods Data were drawn from Adelphi Disease Specific Programme (DSP)™, a real-world, cross-sectional survey PU, NU, physicians United States between December 2021 June 2022. completed distinct questionnaires....